PortfoliosLab logo

Black Diamond Therapeutics, Inc. (BDTX)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Black Diamond Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $413 for a total return of roughly -95.87%. All prices are adjusted for splits and dividends.

BDTX (Black Diamond Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BDTX

Black Diamond Therapeutics, Inc.


Black Diamond Therapeutics, Inc. had a return of -9.44% year-to-date (YTD) and -44.37% in the last 12 months. Over the past 10 years, Black Diamond Therapeutics, Inc. had an annualized return of -63.91%, while the S&P 500 had an annualized return of 5.80%, indicating that Black Diamond Therapeutics, Inc. did not perform as well as the benchmark.

1 month-42.81%-5.31%
6 months-37.79%0.39%
1 year-44.37%-10.12%
5 years (annualized)-63.91%5.80%
10 years (annualized)-63.91%5.80%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Black Diamond Therapeutics, Inc. Sharpe ratio is -0.55. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BDTX (Black Diamond Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Black Diamond Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BDTX (Black Diamond Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Black Diamond Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Black Diamond Therapeutics, Inc. is 97.17%, recorded on Oct 13, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-97.17%Jun 23, 2020583Oct 13, 2022
-53.95%Jan 31, 202033Mar 18, 202026Apr 24, 202059
-19.84%May 13, 202022Jun 12, 20206Jun 22, 202028
-17.8%Apr 28, 20204May 1, 20205May 8, 20209

Volatility Chart

Current Black Diamond Therapeutics, Inc. volatility is 141.80%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BDTX (Black Diamond Therapeutics, Inc.)
Benchmark (^GSPC)